Kesatuan Eropah - Inggeris - EMA (European Medicines Agency)

techdow pharma netherlands b.v.  - enoxaparin sodium - venous thromboembolism - antithrombotic agents - inhixa is indicated for adults for:prophylaxis of venous thromboembolism, particularly in patients undergoing orthopaedic, general or oncological surgery.prophylaxis of venous thromboembolism in patients bedridden due to acute illnesses including acute heart failure, acute respiratory failure, severe infections, as well as exacerbation of rheumatic diseases causing immobilisation of the patient (applies to strengths of 40 mg/0.4 ml).treatment of deep vein thrombosis (dvt), complicated or uncomplicated by pulmonary embolism.treatment of unstable angina and non q wave myocardial infarction, in combination with acetylsalicylic acid (asa).treatment of acute st segment elevation myocardial infarction (stemi) including patients who will be treated conservatively or who will later undergo percutaneous coronary angioplasty (applies to strengths of 60 mg/0.6 ml, 80 mg/0.8 ml, and 100 mg/1 ml).blood clot prevention in the extracorporeal circulation during haemodialysis.

Kesatuan Eropah - Inggeris - EMA (European Medicines Agency)

pharmathen s.a. - enoxaparin sodium - venous thromboembolism - antithrombotic agents - thorinane is indicated for adults for: - prophylaxis of venous thromboembolism, particularly in patients undergoing orthopaedic, general or oncological surgery. - prophylaxis of venous thromboembolism in patients bedridden due to acute illnesses including acute heart failure, acute respiratory failure, severe infections, as well as exacerbation of rheumatic diseases causing immobilisation of the patient (applies to strengths of 40 mg/0.4 ml). - treatment of deep vein thrombosis (dvt), complicated or uncomplicated by pulmonary embolism. - treatment of unstable angina and non q wave myocardial infarction, in combination with acetylsalicylic acid (asa). - treatment of acute st segment elevation myocardial infarction (stemi) including patients who will be treated conservatively or who will later undergo percutaneous coronary angioplasty (applies to strengths of 60 mg/0.6 ml, 80 mg/0.8 ml, and 100 mg/1 ml). - blood clot prevention in the extracorporeal circulation during haemodialysis. prevention and treatment of various disorders related to blood clots in adults.,

Kanada - Inggeris - Health Canada

fresenius kabi canada ltd - enoxaparin sodium - solution - 100mg - enoxaparin sodium 100mg

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - enoxaparin sodium 150 mg/ml;   - solution for injection - 150 mg/ml - active: enoxaparin sodium 150 mg/ml   excipient: water for injection - treatment of venous thromboembolic disease.

Singapura - Inggeris - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - enoxaparin sodium - injection - 10000 anti-xa iu (100mg)/1ml

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - enoxaparin sodium -

United Kingdom - Inggeris - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - enoxaparin sodium - solution for injection - 100mg/1ml

United Kingdom - Inggeris - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - enoxaparin sodium - solution for injection - 100mg/1ml

United Kingdom - Inggeris - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - enoxaparin sodium - solution for injection - 100mg/1ml

United Kingdom - Inggeris - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - enoxaparin sodium - solution for injection - 100mg/1ml